Consolidated Edison of New York, Con Ed's largest subsidiary, reached what we consider a constructive settlement in early 2023 that set electric and gas base rates in 2023-25. The cumulative $1.9 ...

Despite stocks' strong overall performance in 2024, investors may find tax losses in their portfolios to offset gains.

And the key to lower mortgage rates could be in billionaire Elon Musk's hands, the NAR's chief economist Lawrence Yun said Wednesday in a statement after the release of the latest inflation data.

U.K. consumer-protection group Which? said it filed a 3 billion-pound ($3.82 billion) lawsuit against Apple, claiming the iPhone maker breached competition rules by tying consumers to its iCloud ...

--Off 5.26% from its 52-week high of 1.3415 hit Tuesday, Sept. 24, 2024 --Up 2.92% from its 52-week low of 1.2349 hit Monday, April 22, 2024 --Rose 2.35% vs the dollar from 52 weeks ago ...

The Dow edged up, while bitcoin prices topped $90,000 for the first time. The S&P 500 eked out a slim gain of less than 0.1%, while the tech-heavy Nasdaq slipped 0.3%. Inflation Stays Firm, but Not ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

Shares of technology companies fell, giving back some of their recent gains as some of the euphoria about a Republican electoral victory wore off, partly because of puzzling cabinet picks.

Shares of power producers ticked down as traders remained wary of elevated Treasury yields. Yields finished mixed, hovering around multimonth highs amid concerns about the inflationary implications of ...

The Vanguard Group Inc. has increased its position in GameStop Corp., according to a 13-F filing, with the asset-management giant's stake in the videogame retailer now surpassing that of GameStop ...

The Wisconsin Housing and Economic Development Authority plans to sell $215 million of home ownership revenue bonds, with proceeds slated for the purchase of mortgage-backed securities backed by pools ...

AN2 Therapeutics said it was planning to meet with the U.S. Food and Drug Administration to discuss a development path for epetraborole, a treatment of non-tuberculous mycobacterial lung disease. The ...